Physician profile
Ivan Pena
NPI 1770978587
$19,808.62
in general payments reported to CMS, 2019-2025
35 companies · $4,165 in 2025
The $4,165 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $255 · 2021: $597 · 2022: $3,195 · 2023: $8,098 · 2024: $2,927 · 2025: $4,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $4,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,274.69 |
| Travel and Lodging | $4,915.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $6,764.60 | 2022-2025 | Indigo System |
| Abbott Laboratories | $2,897.49 | 2019-2023 | Optis, Diamondback Coronary, Dragonfly Opstar |
| Medtronic, INC. | $2,417.73 | 2021-2025 | Simulus, Ffrangio |
| Teleflex LLC | $1,657.66 | 2023-2025 | Trapliner, Turnpike, Guideliner |
| Boston Scientific Corporation | $1,182.83 | 2022-2025 | Avvigo Guidance System, Watchman Access System, General - Balloon Catheters |
| Pfizer INC. | $902.17 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $615.83 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $485.67 | 2021-2024 | Farxiga, Brilinta, Andexxa |
| Shockwave Medical, INC | $460.41 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $444.01 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $264.26 | 2023-2024 | Xarelto |
| Abiomed | $216.58 | 2023-2025 | Impella |
| Terumo Medical Corporation | $207.90 | 2023-2024 | Metacross Otw |
| Philips North America LLC | $144.09 | 2022-2025 | Mcot |
| Asahi Intecc USA, INC. | $142.16 | 2024 | Peripheral Vascular |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $136.79 | 2021 | |
| Merck Sharp & Dohme LLC | $132.90 | 2023-2025 | Verquvo |
| Astellas Pharma US INC | $99.00 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $98.30 | 2024 | |
| Amgen INC. | $75.77 | 2022-2024 | Repatha |
| Chiesi USA, INC. | $75.13 | 2022 | |
| Reflow Medical INC | $63.45 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.45 | 2023-2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $34.24 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $34.01 | 2021 | |
| Scpharmaceuticals INC. | $28.02 | 2024 | |
| Stryker Corporation | $27.98 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Cardiovascular Systems INC. | $24.55 | 2022-2023 | Diamondback Coronary |
| Alnylam Pharmaceuticals INC. | $23.75 | 2025 | Onpattro |
| Lantheus Medical Imaging, INC. | $19.39 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.84 | 2023 | Evkeeza |
| Novo Nordisk INC | $16.61 | 2025 | Ozempic, Rybelsus |
| Atricure, INC. | $15.38 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.39 | 2024 | |
| Irhythm Technologies, INC. | $14.28 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Pena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.